Today its a new pick. RXII Pharmaceutical.
7:08 am RXi Pharma to present new data in its first Phase 2a clinical trial with RXI-109 (RXII) : Co announced that a review of the first two enrolled patients' clinical photographs in the first Phase 2a clinical trial (RXI-109-1301), indicate that treatment with the company's lead clinical candidate, RXI-109, may be effective in suppressing recurrence of hypertrophic scars at the 3-month time point. Patients will continue to be monitored through 9 months to evaluate if this outcome persists over time.
- Today's presentation will provide 3-month photographs from the first two patients enrolled in study RXI-109-1301 that indicate treatment with RXI-109 shows a clinical benefit. The safety information in this ongoing study to date, continues to confirm that RXI-109 is well tolerated with no overt systemic side effects. Local effects are mild and similar to those seen in the Company's prior Phase 1 clinical trials (erythema, occasional, transient burning or stinging sensation).
- Complete 3-month results from this trial are expected to be available in Q1 2015.
- The presentation will be webcast today, Tuesday, October 7, 2014 at 10:00 a.m. PST, at the 13th Annual BIO Investor Forum
The options are a little thin on RXII so I am going to short it:
| Prev Close: | 1.89 |
|---|---|
| Open: | 1.91 |
| Bid: | 2.19 x 9900 |
| Ask: | 2.20 x 900 |
| 1y Target Est: | 10.17 |
| Beta: | 2.04 |
| Next Earnings Date: | N/A |
| Day's Range: | 1.91 - 2.30 |
|---|---|
| 52wk Range: | 1.76 - 6.84 |
| Volume: | 1,009,185 |
| Avg Vol (3m): | 483,828 |
| Market Cap: | 35.31M |
| P/E (ttm): | N/A |
| EPS (ttm): | -1.16 |
| Div & Yield: | N/A (N/A |
I expect that due to the fact that
1) This is only Phase 2 of 4 phases
2) Phase 2 isn't even complete, there is still 6 more months- plus only two patients??
3) They wont even announce the results of phase 2 until 2015
4) The FDA could cancel this approval process at any time
5) If approved down the line, it will be years before any money comes in to this company
So that will be a short for that at the above entry price.
Now for PBR:
I am going to fly by the seat of my pants and double down. The news still didn't change, and investors are being erroneously hopeful that their man is going to win and hes not, so the public is erroneously still continuing to buy this stock.
NEW YORK (TheStreet) -- Shares of Petrobras (PBR) rose for a second consecutive day Tuesday after Brazil's presidential election on Sunday resulted in a runoff to be held on October 26.
Incumbent Dilma Rousseff received 41.59% of the votes, while challenger Aecio Neves received 33.54%. Marina Silva, who had been gaining ground in the polls and moved into second place, finished third in Sunday's election with 21.31% of the votes.
The leading candidate required more than 50% of valid votes or more than all other candidates combined to win the election in the first round on Sunday and prevent the second round on October 26.
Must Read: Warren Buffett's 25 Favorite Stocks
Investors took the tight election as a positive sign for Brazilian stocks, which have typically fallen in recent weeks when polls showed Rousseff in the lead, but the stocks have risen when her opponents have chipped into her lead.
The stock was up 6.96% to $16.90 at 10:52 a.m.
Separately, TheStreet Ratings team rates PETROBRAS-PETROLEO BRASILIER as a "hold" with a ratings score of C. TheStreet Ratings Team has this to say about their recommendation:
"We rate PETROBRAS-PETROLEO BRASILIER (PBR) a HOLD. The primary factors that have impacted our rating are mixed - some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins."
Highlights from the analysis by TheStreet Ratings Team goes as follows:
- PBR's revenue growth has slightly outpaced the industry average of 3.0%. Since the same quarter one year prior, revenues slightly increased by 3.8%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
- PBR's debt-to-equity ratio of 0.84 is somewhat low overall, but it is high when compared to the industry average, implying that the management of the debt levels should be evaluated further. Regardless of the somewhat mixed results with the debt-to-equity ratio, the company's quick ratio of 1.30 is sturdy.
- The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Oil, Gas & Consumable Fuels industry. The net income has significantly decreased by 25.7% when compared to the same quarter one year ago, falling from $2,996.00 million to $2,225.00 million.
- The company's current return on equity has slightly decreased from the same quarter one year prior. This implies a minor weakness in the organization. In comparison to the other companies in the Oil, Gas & Consumable Fuels industry and the overall market, PETROBRAS-PETROLEO BRASILIER's return on equity is significantly below that of the industry average and is below that of the S&P 500.
- You can view the full analysis from the report here: PBR Ratings Report
| 16.00 | PBR141122P00016000 | 1.93 |  0.39 | 1.92 | 1.94 | 1,011 | 71,668 |
Am I flying by the seat of my ass with this? Yes I am. But I know that I am correct with my assessment which candidate is going to win and that the crowd is being overly enthusiastic with their Romney pro business candidate. Today I double my in and actually go with the Oct 16's.
Be careful with this. It is possible that people could continue to pile on this stock betting and hoping. And we might have to hold for a week or two as it comes closer to the election. I understand erosion will be a factor, but if the price channels around between our strike prices as the election manifests a W for our candidate, the stock will collapse and seeing that our expiration date is November, there is a good chance it will deflate past 16 dollars. So we are going to hold these and only if things go our way early we will bail.
Thats all for today everyone,
Mark
.png "English"){kind=small}
0 comments:
Post a Comment